Not to be pedantic, but an impressive pharmaceutical industry is not the same as leading cancer research. Still impressive. Not the same. Again, I get your point, but no need to exaggerate realities.
The only people pushing “provider” are administrators who would prefer to muddy the waters with regards to who providers care, and the midlevels who benefit.
You can feel about it however you’d like, but the term provider was purposely used to justify different care without patients being aware.
It’s not a matter of a 30 year PA vs a resident, experience certainly matters. But I take issue when you claim medical knowledge because you’re a “provider”, and especially because you work in a pediatric hospital. The role of a pediatric endocrinologist and an ortho PA almost don’t overlap, and the background schooling almost don’t either.
That’s not to say I’m particularly qualified either (it’s outside my specialty) but you infer that you’re qualified to comment when you and I both know, frankly, you’re not.
Congress voted against funding a cure for cancer just to block a win for Biden (www.usatoday.com)
Trans youth will no longer be prescribed puberty blockers, NHS England says (www.thepinknews.com)
Trans youth will no longer be prescribed puberty blockers at NHS England gender identity clinics in a new “blow” to gender-affirming healthcare....
thank you nurse meowsalot (lemmy.world)